Exerte Partners
Overview
Exerte Partners is a single-family office with a global investment focus that backs founders building unique solutions and disruptive technologies with strong IP, particularly in the foodtech, agtech, biotech, biopharma, healthtech, and medtech sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Proteme | Jul 2023 | Pre Seed | Co-investor |
| OCON Therapeutics | Jun 2024 | VC Round | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Exerte Partners based?
Exerte Partners is headquartered in Nicosia, Cyprus.
When was Exerte Partners founded?
Exerte Partners was founded in 2014.
How many portfolio companies does Exerte Partners have?
Exerte Partners has 2 portfolio companies in Caplight's dataset.
What are some companies in Exerte Partners's portfolio?
Portfolio companies visible on Caplight include Proteme, OCON Therapeutics.
What was Exerte Partners's most recent investment shown here?
Exerte Partners's most recent investment in this portfolio sample was in OCON Therapeutics in 2024.
What sectors does Exerte Partners focus on?
Exerte Partners focuses on Healthcare & Life Sciences, Energy & Sustainability, Frontier & Industrial Tech.
What company stages does Exerte Partners focus on?
Exerte Partners typically invests at the Early stage.